PTEN frameshift variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) HC (1) | ER positive, HER2-negative, PTEN frameshift variants | Invasive Breast Carcinoma | Capivasertib, Fulvestrant | |
| FDA (1) HC (1) | HER2-negative, PR positive, PTEN frameshift variants | Invasive Breast Carcinoma | Capivasertib, Fulvestrant | |
| FDA (1) HC (1) | ER positive, HER2-negative, PR positive, PTEN frameshift variants | Invasive Breast Carcinoma | Capivasertib, Fulvestrant |